Search results
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
Yahoo Finance· 3 days agoNovavax struggled after its COVID-19 vaccine was delayed by manufacturing issues early in...
National Academies Report: COVID-19 Vaccines Don’t Cause Many Potential Harms
Journal of the American Medical Association· 4 days agoThe COVID-19 vaccines made by Pfizer-BioNTech and Moderna do not cause such conditions as female infertility, myocardial infarction, Bell palsy, or Guillain-Barré syndrome ...
Forget Nvidia: These 3 Small-Cap Stocks Offer Up to 557% Upside, According to Select Wall Street...
Motley Fool via Yahoo Finance· 5 days agoHowever, management delayed filing an emergency use authorization (EUA) application in the U.S., and...
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
Bloomberg via Yahoo Finance· 3 days ago(Bloomberg) -- Novavax Inc. shares surged after the company signed a $1.2 billion licensing...
AstraZeneca asks for European authorisation of COVID vaccine to be pulled
Euronews via Yahoo News· 5 days agoBillions of doses of the AstraZeneca vaccine were distributed to poorer countries through a...
Novavax strikes $1.2 billion deal with Sanofi in major turnaround
Axios· 3 days agoThe French drug giant Sanofi is taking a minority stake in Novavax and entering into a licensing...
Moderna’s mRNA dreams meet reality with first post-COVID shot - The Boston Globe
The Boston Globe· 4 days agoModerna’s stock dropped 45 percent last year, making it the worst-performing large biotech in the...
Moderna’s First Vaccine Was a Big Hit. Its Second Is a Let Down
Bloomberg via Yahoo Finance· 5 days ago(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion...
Novavax Stock Surges 140% on $1.4 Billion Deal With Sanofi
Barrons.com· 4 days agoNovavax the pharmaceutical company that last year warned that falling sales of its Covid-19 vaccine...
UPDATE 2-Evonik expects Q2 core profit in line with Q1, confirms 2024 outlook
Reuters via Yahoo Finance· 6 days agoGerman chemicals group Evonik Industries said on Wednesday it expects its results to be strong in the second quarter, but is keeping its full-year guidance unchanged due to ongoing uncertainty ...